Tamiflu Renal Dose

SETELDOC • MALAYSIAN PRIMARY CARE

Oseltamivir
Renal Dose

Renal-adjusted influenza treatment and post-exposure prevention dosing for adults and adolescents aged 13 years and older.

✓ Treatment✓ Post-exposure prevention✓ Dialysis guidance

Select the clinical purpose and renal status. For patients not on dialysis, enter an already established creatinine clearance (CrCl). This tool does not calculate CrCl.

QUICK REFERENCE

Oseltamivir renal adjustment

Malaysian Tamiflu product-insert dosing for adults and adolescents aged 13–17 years.

Treatment of influenza

Renal statusTreatment dose60 mg/5 mL equivalent
CrCl >60 mL/min75 mg BD × 5 days6.25 mL per dose
CrCl >30–60 mL/min30 mg BD × 5 days2.5 mL per dose
CrCl >10–30 mL/min30 mg OD × 5 days2.5 mL per dose
CrCl ≤10 mL/minNot recommended—
Haemodialysis30 mg after each haemodialysis session2.5 mL per dose
CAPD30 mg single dose2.5 mL

Post-exposure prevention

Renal statusPrevention dose60 mg/5 mL equivalent
CrCl >60 mL/min75 mg OD6.25 mL per dose
CrCl >30–60 mL/min30 mg OD2.5 mL per dose
CrCl >10–30 mL/min30 mg every second day2.5 mL per dose
CrCl ≤10 mL/minNot recommended—
Haemodialysis30 mg after every second haemodialysis session2.5 mL per dose
CAPD30 mg once weekly2.5 mL per dose

Paediatric renal impairment: no dosing recommendation is available in the Malaysian product insert for infants and children aged 12 years and younger because clinical data are insufficient.

Famous Tool

Paediatric Dose Calculator Demo

If you want a faster clinic workflow, use the full SetelDoc Dose Calculator with over 30 medicines.

kg
Sample preview only. Full access includes the complete medicine list, drug-specific age limits and clinical notes.
CLINICAL NOTES

Important renal-dosing details

CrCl, not eGFRThe Malaysian product insert presents the adjustment according to creatinine clearance. This page does not calculate CrCl.
Age ≤12 yearsInsufficient clinical data are available to make a renal dosing recommendation in infants and children aged 12 years and younger.
CAPD vs APDThe dialysis data are derived from continuous ambulatory peritoneal dialysis (CAPD). The product insert notes that oseltamivir-carboxylate clearance is expected to be higher with automated peritoneal dialysis (APD), so CAPD dosing should not simply be assumed for APD.
PreventionThe prevention renal doses are from the Malaysian NPRA-approved Tamiflu product insert. Current FUKKM lists oseltamivir for treatment and states not to use it as prophylaxis.
ImmunocompromisedThe product insert recommends a longer 10-day treatment course in immunocompromised patients; renal doses still require the relevant adjustment.
COMMON QUESTIONS

Oseltamivir renal-dose FAQ

What is the oseltamivir treatment dose at CrCl 45 mL/min?

For an adult or adolescent aged 13 years or older with a creatinine clearance above 30 and up to 60 mL/min, the Malaysian product insert recommends 30 mg BD. For a standard uncomplicated treatment course this is given for 5 days.

What is the treatment dose at CrCl 20 mL/min?

At creatinine clearance above 10 and up to 30 mL/min, the recommended treatment dose is 30 mg OD.

What happens when CrCl is 10 mL/min or lower?

The current Malaysian Tamiflu product insert lists oseltamivir as not recommended at CrCl ≤10 mL/min because dosing data are unavailable.

What dose is used in haemodialysis?

For treatment, the product insert gives 30 mg after each haemodialysis session. For prevention, it gives 30 mg after every second haemodialysis session.

What dose is used in CAPD?

For treatment, the product insert gives 30 mg as a single dose. For prevention, it gives 30 mg once weekly. These data are derived from CAPD and should not automatically be applied to APD.

Can I use this renal calculator in a child aged 12 years or younger?

No renal dosing recommendation is available from the current Malaysian Tamiflu product insert for this age group because clinical data are insufficient.

RELATED OSELTAMIVIR DOSING

Other Tamiflu dosing references

Clinical references

  1. Malaysian NPRA / QUEST3+ — Tamiflu product insert — renal adjustment for treatment and prevention, haemodialysis, CAPD and paediatric renal limitations.
  2. Ministry of Health Malaysia — FUKKM: Oseltamivir — 60 mg/5 mL oral suspension, standard treatment dosing and instruction to follow the manufacturer product insert for renal dose adjustment.

For healthcare professionals. This page supports but does not replace clinical judgement. Confirm renal function, dialysis modality, treatment purpose, formulation and current product information before prescribing.

Top
VIP
Free
Login | Out
Help
Scroll to Top